Corey N. Fishman - 06 Aug 2024 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ITRM
Reported as of: 06 Aug 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 12 Aug 2024, 09:00:04 UTC
Prior SEC filing: 20 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Corey N. Fishman

Filing notes and source

Key filing fact

Corey N. Fishman filed Form 4 for Iterum Therapeutics plc (ITRM) on 12 Aug 2024.

Key facts

This page summarizes Corey N. Fishman's Form 4 filing for Iterum Therapeutics plc (ITRM).
4 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 12 Aug 2024, 09:00.

Change

Previous filing in this sequence was filed on 20 Nov 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ITRM transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +82,613
Change %: +152%
Price
Shares after: 137,062
Date: 06 Aug 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ITRM transaction Derivative

Subscription Rights (right to buy)

Options Exercise

Transaction value: $0
Shares: -165,226
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 06 Aug 2024
Ownership: Direct
Underlying class: Units
Underlying amount
Exercise price: $0.6100
Footnotes: F1, F2

ITRM transaction Derivative

Warrants (right to buy)

Options Exercise

Transaction value
Shares: +82,613
Change %
Price
Shares after: 82,613
Date: 06 Aug 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 41,306
Exercise price: $1.21
Footnotes: F1

ITRM transaction Derivative

Warrants (right to buy)

Options Exercise

Transaction value
Shares: +82,613
Change %
Price
Shares after: 82,613
Date: 06 Aug 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 82,613
Exercise price: $1.21
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities were purchased in the Issuer's rights offering (the "Offering") which closed on August 9, 2024. As part of the Offering, the Reporting Person purchased 82,613 units at a subscription price of $1.21 per whole unit. Each unit consisted of (a) one ordinary share, (b) a warrant to purchase 0.50 ordinary shares, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration one year from the date of issuance ("1-year warrants"), and (c) a warrant to purchase one ordinary share, at an exercise price of $1.21 per whole ordinary share from the date of issuance through its expiration five years from the date of issuance ("5-year warrants").

Footnote F2

The Reporting Person validly exercised 165,226 subscription rights to acquire 82,613 units composed of (i) 82,613 ordinary shares, (ii) 82,613 1-year warrants and (iii) 82,613 5-year warrants.